questionsmedicales.fr
Facteurs biologiques
Pigments biologiques
Porphyrines
Porphyrines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Porphyries
Diagnostic médical
Tests génétiques
Porphyries héréditaires
Interprétation des tests
Porphyries
Symptômes
5
Douleur abdominale
Porphyries
Éruption cutanée
Photosensibilité
Troubles neurologiques
Porphyries
Classification des maladies
Porphyries
Prévention
5
Prévention
Déclencheurs de crise
Régime alimentaire
Porphyries
Gestion du stress
Prévention des maladies
Traitements
5
Transfusion sanguine
Anémie
Hématine
Traitement des porphyries
Soins d'urgence
Crises de porphyrie
Photoprotection
Prévention des maladies
Complications
5
Lésions hépatiques
Porphyries
Cancer de la peau
Porphyries
Complications neurologiques
Porphyries
Gestion des complications
Suivi médical
Facteurs de risque
5
Facteurs de risque
Porphyries
Hérédité
Porphyries héréditaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Porphyrines : Questions médicales les plus fréquentes",
"headline": "Porphyrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Porphyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Porphyrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pigments biologiques",
"url": "https://questionsmedicales.fr/mesh/D010860",
"about": {
"@type": "MedicalCondition",
"name": "Pigments biologiques",
"code": {
"@type": "MedicalCode",
"code": "D010860",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Coproporphyrines",
"alternateName": "Coproporphyrins",
"url": "https://questionsmedicales.fr/mesh/D003306",
"about": {
"@type": "MedicalCondition",
"name": "Coproporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D003306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Deutéroporphyrines",
"alternateName": "Deuteroporphyrins",
"url": "https://questionsmedicales.fr/mesh/D003905",
"about": {
"@type": "MedicalCondition",
"name": "Deutéroporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D003905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Étioporphyrines",
"alternateName": "Etioporphyrins",
"url": "https://questionsmedicales.fr/mesh/D005044",
"about": {
"@type": "MedicalCondition",
"name": "Étioporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D005044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.340"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hématoporphyrines",
"alternateName": "Hematoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D006415",
"about": {
"@type": "MedicalCondition",
"name": "Hématoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D006415",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hématoporphyrine D",
"alternateName": "Hematoporphyrin Derivative",
"url": "https://questionsmedicales.fr/mesh/D017324",
"about": {
"@type": "MedicalCondition",
"name": "Hématoporphyrine D",
"code": {
"@type": "MedicalCode",
"code": "D017324",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Éther de dihématoporphyrine",
"alternateName": "Dihematoporphyrin Ether",
"url": "https://questionsmedicales.fr/mesh/D017323",
"about": {
"@type": "MedicalCondition",
"name": "Éther de dihématoporphyrine",
"code": {
"@type": "MedicalCode",
"code": "D017323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Éther de dihématoporphyrine",
"alternateName": "Dihematoporphyrin Ether",
"url": "https://questionsmedicales.fr/mesh/D017323",
"about": {
"@type": "MedicalCondition",
"name": "Éther de dihématoporphyrine",
"code": {
"@type": "MedicalCode",
"code": "D017323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Mésoporphyrines",
"alternateName": "Mesoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D008652",
"about": {
"@type": "MedicalCondition",
"name": "Mésoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D008652",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.620"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métalloporphyrines",
"alternateName": "Metalloporphyrins",
"url": "https://questionsmedicales.fr/mesh/D008665",
"about": {
"@type": "MedicalCondition",
"name": "Métalloporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D008665",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hème",
"alternateName": "Heme",
"url": "https://questionsmedicales.fr/mesh/D006418",
"about": {
"@type": "MedicalCondition",
"name": "Hème",
"code": {
"@type": "MedicalCode",
"code": "D006418",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hémine",
"alternateName": "Hemin",
"url": "https://questionsmedicales.fr/mesh/D006427",
"about": {
"@type": "MedicalCondition",
"name": "Hémine",
"code": {
"@type": "MedicalCode",
"code": "D006427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587.462"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hémine",
"alternateName": "Hemin",
"url": "https://questionsmedicales.fr/mesh/D006427",
"about": {
"@type": "MedicalCondition",
"name": "Hémine",
"code": {
"@type": "MedicalCode",
"code": "D006427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587.462"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protoporphyrines",
"alternateName": "Protoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D011524",
"about": {
"@type": "MedicalCondition",
"name": "Protoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D011524",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uroporphyrines",
"alternateName": "Uroporphyrins",
"url": "https://questionsmedicales.fr/mesh/D014578",
"about": {
"@type": "MedicalCondition",
"name": "Uroporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D014578",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.880"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Porphyrines",
"alternateName": "Porphyrins",
"code": {
"@type": "MedicalCode",
"code": "D011166",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Harry L Anderson",
"url": "https://questionsmedicales.fr/author/Harry%20L%20Anderson",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK."
}
},
{
"@type": "Person",
"name": "Donato Monti",
"url": "https://questionsmedicales.fr/author/Donato%20Monti",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Sapienza, University of Rome Piazzale Aldo Moro 5 00185 Rome Italy."
}
},
{
"@type": "Person",
"name": "Manuela Stefanelli",
"url": "https://questionsmedicales.fr/author/Manuela%20Stefanelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
},
{
"@type": "Person",
"name": "Gabriele Magna",
"url": "https://questionsmedicales.fr/author/Gabriele%20Magna",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
},
{
"@type": "Person",
"name": "Roberto Paolesse",
"url": "https://questionsmedicales.fr/author/Roberto%20Paolesse",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Offensive language detection in low resource languages: A use case of Persian language.",
"datePublished": "2024-06-21",
"url": "https://questionsmedicales.fr/article/38905214",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0304166"
}
},
{
"@type": "ScholarlyArticle",
"name": "Geography and language divergence: The case of Andic languages.",
"datePublished": "2022-05-26",
"url": "https://questionsmedicales.fr/article/35617249",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0265460"
}
},
{
"@type": "ScholarlyArticle",
"name": "An investigation across 45 languages and 12 language families reveals a universal language network.",
"datePublished": "2022-07-18",
"url": "https://questionsmedicales.fr/article/35856094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41593-022-01114-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Language Environment at Home of Children With (a Suspicion of) a Developmental Language Disorder and Relations With Standardized Language Measures.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37418756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2023_JSLHR-23-00066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adaptive Language Mapping Paradigms for Presurgical Language Mapping.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36137653",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3174/ajnr.A7629"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pigments biologiques",
"item": "https://questionsmedicales.fr/mesh/D010860"
},
{
"@type": "ListItem",
"position": 4,
"name": "Porphyrines",
"item": "https://questionsmedicales.fr/mesh/D011166"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Porphyrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Porphyrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Porphyrines",
"description": "Comment diagnostiquer une porphyrie ?\nQuels tests sont utilisés pour les porphyrines ?\nQuels symptômes indiquent une porphyrie ?\nLes tests génétiques sont-ils nécessaires ?\nComment interpréter les résultats des tests ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Language#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Porphyrines",
"description": "Quels sont les symptômes courants des porphyries ?\nLes porphyries causent-elles des douleurs ?\nY a-t-il des symptômes cutanés ?\nLes porphyries affectent-elles le système nerveux ?\nLes symptômes varient-ils selon le type de porphyrie ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Language#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Porphyrines",
"description": "Comment prévenir les crises de porphyrie ?\nY a-t-il des conseils diététiques pour les patients ?\nLes patients doivent-ils éviter certains médicaments ?\nLa gestion du stress est-elle importante ?\nLes patients doivent-ils être suivis régulièrement ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Language#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Porphyrines",
"description": "Quel est le traitement principal des porphyries ?\nLes transfusions sanguines sont-elles nécessaires ?\nY a-t-il des médicaments spécifiques pour les porphyries ?\nComment gérer les crises de porphyrie ?\nLa photoprotection est-elle recommandée ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Language#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Porphyrines",
"description": "Quelles sont les complications possibles des porphyries ?\nLes porphyries peuvent-elles causer des dommages au foie ?\nY a-t-il un risque accru de cancer ?\nLes complications neurologiques sont-elles fréquentes ?\nComment gérer les complications des porphyries ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Language#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Porphyrines",
"description": "Quels sont les facteurs de risque des porphyries ?\nL'hérédité joue-t-elle un rôle ?\nLes femmes sont-elles plus à risque ?\nL'alcool augmente-t-il le risque ?\nLes infections peuvent-elles aggraver la condition ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Language#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une porphyrie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins et urinaires pour mesurer les niveaux de porphyrines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les porphyrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'analyse des urines, du sang et parfois des biopsies de peau."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une porphyrie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des douleurs abdominales, des troubles neurologiques et des photosensibilités."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent aider à confirmer certains types de porphyries héréditaires."
}
},
{
"@type": "Question",
"name": "Comment interpréter les résultats des tests ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de porphyrines dans le sang ou l'urine indiquent une porphyrie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des porphyries ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des éruptions cutanées et des troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les porphyries causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales aiguës sont fréquentes lors des crises de porphyrie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées et une photosensibilité peuvent survenir, surtout dans la porphyrie cutanée."
}
},
{
"@type": "Question",
"name": "Les porphyries affectent-elles le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des troubles neurologiques, y compris des crises et des hallucinations."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de porphyrie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de porphyrie présente des symptômes spécifiques et des manifestations cliniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crises de porphyrie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs comme certains médicaments, l'alcool et le stress peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques pour les patients ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en glucides peut aider à prévenir les crises."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent déclencher des crises et doivent être évités."
}
},
{
"@type": "Question",
"name": "La gestion du stress est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress est cruciale pour prévenir les crises de porphyrie."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils être suivis régulièrement ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier est essentiel pour surveiller l'évolution de la maladie."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal des porphyries ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut l'évitement des déclencheurs et des médicaments pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des transfusions peuvent être nécessaires pour traiter l'anémie associée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques pour les porphyries ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'hématine peuvent être utilisés pour traiter les crises aiguës de porphyrie."
}
},
{
"@type": "Question",
"name": "Comment gérer les crises de porphyrie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les crises peuvent être gérées par des soins d'urgence et des traitements symptomatiques."
}
},
{
"@type": "Question",
"name": "La photoprotection est-elle recommandée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients doivent éviter l'exposition au soleil et utiliser des écrans solaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des porphyries ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions nerveuses, des problèmes hépatiques et des infections."
}
},
{
"@type": "Question",
"name": "Les porphyries peuvent-elles causer des dommages au foie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines porphyries peuvent entraîner des lésions hépatiques graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines porphyries, comme la porphyrie cutanée, peuvent augmenter le risque de cancer de la peau."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques peuvent survenir, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des porphyries ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des porphyries ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, certains médicaments et des conditions hépatiques."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines porphyries sont héréditaires et peuvent être transmises dans les familles."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études montrent que les femmes peuvent être plus touchées par certaines porphyries."
}
},
{
"@type": "Question",
"name": "L'alcool augmente-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la consommation d'alcool peut déclencher des crises chez les personnes prédisposées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver la condition ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes des porphyries."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/02/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK.
Publications dans "Porphyrines" :
5 publications dans cette catégorie
Affiliations :
Department of Chemistry, Sapienza, University of Rome Piazzale Aldo Moro 5 00185 Rome Italy.
Publications dans "Porphyrines" :
5 publications dans cette catégorie
Affiliations :
Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it.
Publications dans "Porphyrines" :
4 publications dans cette catégorie
Affiliations :
Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it.
Publications dans "Porphyrines" :
4 publications dans cette catégorie
Affiliations :
Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it.
Publications dans "Porphyrines" :
3 publications dans cette catégorie
Affiliations :
Department of Electronic Engineering, University of Rome Tor Vergata via del Politecnico 1 00133 Rome Italy.
Publications dans "Porphyrines" :
3 publications dans cette catégorie
Affiliations :
CNR-ISMN, Istituto per lo Studio dei Materiali Nanostrutturati c/o Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, University of Messina V. le F. Stagno D'Alcontres, 3198166 Messina, Italy. maria.castriciano@cnr.it.
Publications dans "Porphyrines" :
3 publications dans cette catégorie
Affiliations :
CNR-ISMN, Istituto per lo Studio dei Materiali Nanostrutturati c/o Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, University of Messina V. le F. Stagno D'Alcontres, 3198166 Messina, Italy.
Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali and C.I.R.C.M.S.B., University of Messina V. le F. Stagno D'Alcontres, 3198166 Messina, Italy.
Publications dans "Porphyrines" :
3 publications dans cette catégorie
Affiliations :
CNR-ISMN, Istituto per lo Studio dei Materiali Nanostrutturati c/o Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, University of Messina V. le F. Stagno D'Alcontres, 3198166 Messina, Italy. lmonsu@unime.it.
Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali and C.I.R.C.M.S.B., University of Messina V. le F. Stagno D'Alcontres, 3198166 Messina, Italy. lmonsu@unime.it.
Publications dans "Porphyrines" :
3 publications dans cette catégorie
Affiliations :
Department of Chemical Science and Technologies, University of Rome Tor Vergata, Roma, Italy.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Université de Bourgogne, Institut de Chimie Moléculaire de l'Université de Bourgogne, 9 avenue Alain Savary, 21078, Dijon, FRANCE.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Graduate School of Science, Kyoto University Sakyo-ku, Kyoto, 606-8502, Japan.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
CNR-ISMN, Istituto per lo Studio dei Materiali Nanostrutturati c/o Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, University of Messina V. le F. Stagno D'Alcontres, 3198166 Messina, Italy.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Institute for Molecules and Materials Radboud University Heyendaalseweg 135 6525 AJ Nijmegen The Netherlands.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Institute for Molecules and Materials Radboud University Heyendaalseweg 135 6525 AJ Nijmegen The Netherlands.
Publications dans "Porphyrines" :
2 publications dans cette catégorie
Affiliations :
Institute for Molecules and Materials Radboud University Heyendaalseweg 135 6525 AJ Nijmegen The Netherlands.
Publications dans "Porphyrines" :
THIS ARTICLE USES WORDS OR LANGUAGE THAT IS CONSIDERED PROFANE, VULGAR, OR OFFENSIVE BY SOME READERS. Different types of abusive content such as offensive language, hate speech, aggression, etc. have ...
We study the correlation between phylogenetic and geographic distances for the languages of the Andic branch of the East Caucasian (Nakh-Daghestanian) language family. For several alternative phylogen...
To understand the architecture of human language, it is critical to examine diverse languages; however, most cognitive neuroscience research has focused on only a handful of primarily Indo-European la...
This study compares the home language environments of children with (a suspicion of) developmental language disorder (DLD) with that of children with typical development (TD). It does so by adopting n...
Ninety-nine 2- to 4-year-old toddlers participated: 59 with (a suspicion of) DLD and 40 with TD. LENA metrics on adult word count, conversational turn count, and child vocalization count were obtained...
We found lower adult word count, conversational turn count, and child vocalization count in the DLD group, independent of multilingualism but not of parental education. In the DLD group, receptive voc...
Toddlers with (a suspicion of) DLD vocalize less at home than children with TD. They also hear fewer adult words and experience fewer conversational turns. Children with DLD's language outcomes are to...
Functional MR imaging is widely used for preoperative language assessment in candidates for resective neurosurgery. Language mapping paradigms that are adaptive to participant performance have the pot...
Seventy-three patients undergoing fMRI for language lateralization and/or localization completed an adaptive semantic matching paradigm, an adaptive phonological judgment paradigm, and two standard pa...
The adaptive semantic paradigm resulted in the most strongly lateralized activation maps, the greatest extent of frontal and temporal activations, and the greatest proportion of overall satisfactory l...
The adaptive language mapping paradigms investigated have several psychometric advantages compared with currently recommended paradigms. Adoption of these paradigms could increase the likelihood of ob...
Life expectancy has been increasing in recent decades. Therefore, it is important to understand the functional changes during healthy ageing. Most research has mainly focused on one linguistic domain ...
Twenty-three older healthy Hebrew-speaking adults, exhibiting no cognitive decline, were examined on tasks aimed at testing their performance in different language and cognitive domains: lexical retri...
A decline was found in several linguistic domains among the older adults, while in other domains no decline was found. However, no unequivocal decline in linguistic functioning was found due to relati...
Not all linguistic domains are equally vulnerable in ageing, and not all older adults are equally affected. The research has both clinical and theoretical implications....
Recent research suggests that speaking a tone language confers benefits in processing pitch in nonlinguistic contexts such as music. This research largely compares speakers of nontone European languag...
Speech-language pathologists (SLPs) have multiple roles and responsibilities related to language and literacy instruction in schools. The purpose of this exploratory, qualitative study was to analyze ...
Eight school-based SLPs participated in a 1-hr virtual focus group conducted via Zoom recording technology. The researchers used a conventional content analysis approach to analyze the focus group dat...
The researchers developed two themes: (a) SLPs identified repeated exposure to books, peer interaction, and teaching vocabulary with visual supports and props as key elements of language and literacy ...
SLPs identified several instructional practices inclusive pre-K teachers could be taught to use during professional development programs to support the emergent literacy development of children with D...
What language devises, it might divide. By exploring the relations among the core geometries of the physical world, the abstract geometry of Euclid, and language, I give new insight into both the pers...
Consequences of multilingualism vary from offering cognitive benefits to poor educational and cognitive outcomes. One aspect of multilingualism that has not been systematically examined is the typolog...